M&A Deal Summary

Wyeth Acquires Thiakis Limited

On December 18, 2008, Wyeth acquired life science company Thiakis Limited for 150M USD

Acquisition Highlights
  • This is Wyeth’s 2nd transaction in the Life Science sector.
  • This is Wyeth’s largest (disclosed) transaction.
  • This is Wyeth’s 2nd transaction in the United Kingdom.

M&A Deal Summary

Date 2008-12-18
Target Thiakis Limited
Sector Life Science
Buyer(s) Wyeth
Deal Type Add-on Acquisition
Deal Value 150M USD

Target

Thiakis Limited

London, United Kingdom
Thiakis is the developer of a treatment of severe obesity and comorbidities, including diabetes and heart disease.

Search 200,626 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Wyeth

Collegeville, Pennsylvania, United States

Category Company
Founded 1860
Sector Life Science
Employees50,000
Revenue 22.4B USD (2008)
DESCRIPTION

Wyeth is a research-driven pharmaceutical and health care products company. It discovers, develops, manufactures and markets pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.


DEAL STATS #
Overall 4 of 4
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 3 of 3
Country (United Kingdom) 2 of 2
Year (2008) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-07-15 ThermaCare

Albany, Georgia, United States

ThermaCare is a provider of heat wraps. ThermaCare HeatWraps relieve pain and accelerate healing with therapeutic heat.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-07 ThermaCare

Albany, Georgia, United States

ThermaCare is a provider of heat wraps. ThermaCare HeatWraps relieve pain and accelerate healing with therapeutic heat.

Sell -